The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 224,795 | 2,077,200 | SH | SOLE | 2,077,200 | 0 | 0 | ||
ABIOMED INC | COM | 003654100 | 42,232 | 132,500 | SH | SOLE | 132,500 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 43,775 | 322,800 | SH | SOLE | 322,800 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 10,561 | 2,200,200 | SH | SOLE | 2,200,200 | 0 | 0 | ||
ADICET BIO INC | COM | 007002108 | 29,168 | 2,230,000 | SH | SOLE | 2,230,000 | 0 | 0 | ||
AFFIMED N V | COM | N01045108 | 10,251 | 1,296,000 | SH | SOLE | 1,296,000 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 30,318 | 2,552,000 | SH | SOLE | 2,552,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 60,425 | 427,969 | SH | SOLE | 427,969 | 0 | 0 | ||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 36,854 | 2,334,000 | SH | SOLE | 2,334,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 16,017 | 1,511,000 | SH | SOLE | 1,511,000 | 0 | 0 | ||
AMERICAN WELL CORP | CL A | 03044L105 | 1,220 | 70,250 | SH | SOLE | 70,250 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 1,949 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 62,350 | 898,550 | SH | SOLE | 898,550 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 5,508 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 116,356 | 1,760,300 | SH | SOLE | 1,760,300 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 5,236 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ARYA SCIENCES ACQUISITION CO | COM CL A | G3166W106 | 6,890 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 181,503 | 3,650,500 | SH | SOLE | 3,650,500 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 30,872 | 1,677,845 | SH | SOLE | 1,677,845 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 23,165 | 1,784,000 | SH | SOLE | 1,784,000 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 144,219 | 4,985,100 | SH | SOLE | 4,985,100 | 0 | 0 | ||
BAUSCH HEALTH COS INC | COM | 071734107 | 60,030 | 1,891,300 | SH | SOLE | 1,891,300 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 5,285 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 3,336 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 26,102 | 6,797,400 | SH | SOLE | 6,797,400 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 71,754 | 1,049,800 | SH | SOLE | 1,049,800 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196905 | 35,754 | 523,100 | SH | Call | SOLE | 523,100 | 0 | 0 | |
BIOVENTUS INC | COM CL A | 09075A108 | 19,166 | 1,254,333 | SH | SOLE | 1,254,333 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 53,088 | 546,000 | SH | SOLE | 546,000 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 21,533 | 654,294 | SH | SOLE | 654,294 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 50,210 | 815,100 | SH | SOLE | 815,100 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 22,666 | 2,447,700 | SH | SOLE | 2,447,700 | 0 | 0 | ||
CARDINAL HEALTH INC | COM | 14149Y108 | 88,877 | 1,463,000 | SH | SOLE | 1,463,000 | 0 | 0 | ||
CATALENT INC | COM | 148806102 | 58,974 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 48,207 | 940,800 | SH | SOLE | 940,800 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 21,497 | 2,230,000 | SH | SOLE | 2,230,000 | 0 | 0 | ||
CIGNA CORP NEW | COM | 125523100 | 32,635 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
CM LIFE SCIENCES II INC | UNIT 02/25/2028 | 125842203 | 4,310 | 336,700 | SH | SOLE | 336,700 | 0 | 0 | ||
CM LIFE SCIENCES INC | COM CL A | 18978W109 | 8,190 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 3,667 | 417,710 | SH | SOLE | 417,710 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 17,538 | 740,000 | SH | SOLE | 740,000 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 29,476 | 707,359 | SH | SOLE | 707,359 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 23,249 | 2,053,789 | SH | SOLE | 2,053,789 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 34,405 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 82,502 | 2,840,000 | SH | SOLE | 2,840,000 | 0 | 0 | ||
EVELO BIOSCIENCES INC | COM | 299734103 | 8,560 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 78,804 | 598,000 | SH | SOLE | 598,000 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,362 | 232,504 | SH | SOLE | 232,504 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 20,011 | 2,122,064 | SH | SOLE | 2,122,064 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 29,455 | 1,408,000 | SH | SOLE | 1,408,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 4,476 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HEALTHCOR CATALIO ACQU CORP | CL A SHS | G44125105 | 5,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 4,080 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 53,475 | 581,000 | SH | SOLE | 581,000 | 0 | 0 | ||
I MAB | SPONSORED ADS | 44975P103 | 64,417 | 1,329,000 | SH | SOLE | 1,329,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 34,592 | 1,472,000 | SH | SOLE | 1,472,000 | 0 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | 22,470 | 293,000 | SH | SOLE | 293,000 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 9,916 | 884,600 | SH | SOLE | 884,600 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 23,414 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
INOVIO PHARMACEUTICALS INC | COM NEW | 45773H201 | 37,161 | 4,004,391 | SH | SOLE | 4,004,391 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 10,032 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 103,008 | 139,400 | SH | SOLE | 139,400 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 37,127 | 9,544,200 | SH | SOLE | 9,544,200 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 11,366 | 1,907,081 | SH | SOLE | 1,907,081 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 24,631 | 1,330,700 | SH | SOLE | 1,330,700 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 4,056 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | 98,421 | 2,761,545 | SH | SOLE | 2,761,545 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | UNIT 99/99/9999 | G5960S116 | 5,122 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 120,989 | 1,024,200 | SH | SOLE | 1,024,200 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 10,173 | 487,000 | SH | SOLE | 487,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 81,487 | 475,700 | SH | SOLE | 475,700 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 40,169 | 395,600 | SH | SOLE | 395,600 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 50,706 | 521,400 | SH | SOLE | 521,400 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 78,604 | 7,521,941 | SH | SOLE | 7,521,941 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 267 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
ONCOSEC MED INC | COM | 68234L306 | 16,552 | 3,470,000 | SH | SOLE | 3,470,000 | 0 | 0 | ||
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 31,347 | 4,317,800 | SH | SOLE | 4,317,800 | 0 | 0 | ||
ORGANOGENESIS HLDGS INC | COM | 68621F102 | 26,663 | 1,463,403 | SH | SOLE | 1,463,403 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 11,192 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 14,826 | 4,285,000 | SH | SOLE | 4,285,000 | 0 | 0 | ||
SANA BIOTECHNOLOGY INC | COM | 799566104 | 24,511 | 732,321 | SH | SOLE | 732,321 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 10,034 | 1,263,769 | SH | SOLE | 1,263,769 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 80,247 | 577,900 | SH | SOLE | 577,900 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 38,900 | 1,330,385 | SH | SOLE | 1,330,385 | 0 | 0 | ||
SI BONE INC | COM | 825704109 | 18,373 | 577,570 | SH | SOLE | 577,570 | 0 | 0 | ||
SIGILON THERAPEUTICS INC | COM | 82657L107 | 19,019 | 850,968 | SH | SOLE | 850,968 | 0 | 0 | ||
SOTERA HEALTH CO | COM | 83601L102 | 28,979 | 1,161,000 | SH | SOLE | 1,161,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 85,997 | 3,846,000 | SH | SOLE | 3,846,000 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 8,800 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 43,121 | 4,015,000 | SH | SOLE | 4,015,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 66,809 | 310,900 | SH | SOLE | 310,900 | 0 | 0 | ||
VESPER HEALTHCARE ACQSTN COR | UNIT 99/99/9999 | 92538T203 | 6,930 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 54,815 | 1,263,300 | SH | SOLE | 1,263,300 | 0 | 0 | ||
ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | 52,186 | 326,000 | SH | SOLE | 326,000 | 0 | 0 |